CLINICAL TRIAL

Omega-3 (EPA+DHA) for COVID-19

Recruiting · 18+ · All Sexes · Edison, NJ

This study is evaluating whether omega-3 supplements might help people recover from covid-19.

See full description

About the trial for COVID-19

Treatment Groups

This trial involves 2 different treatments. Omega-3 (EPA+DHA) is the primary treatment being studied. Participants will all receive the same treatment. Some patients will receive a placebo treatment. The treatments being tested are in Phase 1 and are in the first stage of evaluation with people.

Main TreatmentA portion of participants receive this new treatment to see if it outperforms the control.
Omega-3 (EPA+DHA)
DRUG
Control TreatmentAnother portion of participants receive the standard treatment to act as a baseline.
Placebo
DRUG

Eligibility

This trial is for patients born any sex aged 18 and older. There are 10 eligibility criteria to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
The individual has been tested for COVID-19 using a PCR test and the result is positive. show original
The team will be vaccinated and may have a milder case of Covid-19 if they require treatment it will only be outpatient. show original
A team member at Hackensack Meridian Health is someone who works at the New Jersey-based healthcare company show original
Age: 18+
or not The patient should be able to provide his/her own informed consent or not as they see fit show original
Individuals who are experiencing one or more ongoing symptoms from the Covid-19 virus are being studied in this research show original
The symptoms have lasted for more than 12 weeks after the initial infection. show original
Symptom(s) coincided with covid-19 infection and were not present prior to covid-19 infection
This food does not have soy allergy. show original
This person does not have an allergy to fish. show original
View All
Odds of Eligibility
Unknown<50%
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial
Similar Trials

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: 6 months recruitment efforts (starting on actual study start date)
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months recruitment efforts (starting on actual study start date)
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: 6 months recruitment efforts (starting on actual study start date).
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether Omega-3 (EPA+DHA) will improve 3 primary outcomes and 5 secondary outcomes in patients with COVID-19. Measurement will happen over the course of 12 weeks from baseline.

Impact of omega-3 supplement on post-covid symptoms - Loss of taste
12 WEEKS FROM BASELINE
Self-reported loss of taste as captured at baseline (self-completing survey-pre) and after 12 weeks of treatment with omega-3 (self-completing survey-post).
12 WEEKS FROM BASELINE
Impact of omega-3 supplement on post-covid symptoms - Fatigue
12 WEEKS FROM BASELINE
Self-reported fatigue as captured at baseline (self-completing survey-pre) and after 12 weeks of treatment with omega-3 (self-completing survey-post).
12 WEEKS FROM BASELINE
Impact of omega-3 supplement on post-covid symptoms - Cough
12 WEEKS FROM BASELINE
Self-reported cough as captured at baseline (self-completing survey-pre) and after 12 weeks of treatment with omega-3 (self-completing survey-post).
12 WEEKS FROM BASELINE
Impact of omega-3 supplement on post-covid symptoms - Shortness of breath
12 WEEKS FROM BASELINE
Self-reported shortness of breath as captured at baseline (self-completing survey-pre) and after 12 weeks of treatment with omega-3 (self-completing survey-post).
12 WEEKS FROM BASELINE
Impact of omega-3 supplement on post-covid symptoms - Loss of smell
12 WEEKS FROM BASELINE
Self-reported loss of smell as captured at baseline (self-completing survey-pre) and after 12 weeks of treatment with omega-3 (self-completing survey-post).
12 WEEKS FROM BASELINE
Feasibility study for omega-3 fatty acid supplementation v. placebo in adult patients to limit long covid syndrome - Compliance as captured by the number of participants who remain compliant for the whole duration of the study by taking all pills daily
12 WEEKS
Number of participants who remain compliant for 12 weeks
12 WEEKS
See More

Patient Q & A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is covid-19?

In the present study, we investigated the risk of cbd oil exposure in the face of SARS-Cov2, with potential consequences on a subset of the population with regards to risk and prevalence in future pandemics of a new strain of the coronavirus, SARS-Cov2, and its derivatives that have emerged since that time. Results from a recent clinical trial showed a significant increase in cannabidiol serum concentrations in patients exposed to a CBD-containing cannabis product as compared with the control group, who experienced the same exposure without cannabidiol. Results from a recent clinical trial suggest that a cannabinoid-contaminated cannabis product contributes to the emergence of SARS-Cov2.

Anonymous Patient Answer

How many people get covid-19 a year in the United States?

Around 1.8 million people in the United States are infected with the SARS-CoV-2 virus. Since SARS-CoV-2 is spread primarily by the human respiratory route, this is a major public health concern.

Anonymous Patient Answer

What are the signs of covid-19?

Symptoms of covid-19 can be transient for 2 to 14 days. Fever is not the only symptoms which is seen in the patients with covid-19. The most common symptoms of covid-19 are persistent cough, runny nose, fever, chills and headache.

Anonymous Patient Answer

What are common treatments for covid-19?

Results from a recent clinical trial shows that there are two common treatments for Covid-19, supportive therapy and medication. The supportive therapy includes hydration, oxygen, pain management, monitoring of temperature, antipyretics and anti-emetics. Medication choices are dependent on the severity of the symptoms and the patient's willingness to initiate medication. Results from a recent clinical trial of this study can be used for treatment guide for Covid-19 patients and for decision making in the event of an epidemic in a country or region.

Anonymous Patient Answer

What causes covid-19?

Human coronaviruses (mainly 229E) and bovine coronaviruses can cause respiratory illness, and there were more severe cases of respiratory illnesses in close contact, family members, healthcare workers, and laboratory workers in Wuhan. The transmission routes of HCCOV-2 infection were not specified clearly in epidemiological investigations. Therefore, further research to understand the underlying mechanisms of HCCOV-2 infection, and its transmission routes are essential to control the outbreak. It is hoped that it will improve the prevention of and control of the current outbreak.

Anonymous Patient Answer

Can covid-19 be cured?

As of May 24, there has been no cure for covid-19. However, patients can be counseled on what they can expect as we work with this virus, and they can be guided in determining what treatment would be most appropriate.

Anonymous Patient Answer

Does omega-3 (epa+dha) improve quality of life for those with covid-19?

Omega-3 may have a significant beneficial effect on daily living issues like fatigue and mental acuity for those with c-19 infection. Patients may require more support/assessment to gain improvements in daily living.

Anonymous Patient Answer

What is the primary cause of covid-19?

There is no evidence to suggest that human-to-human transmission is more important in [the pathogenesis of SARS-CoV-2 or its associated disease, COVID-19] compared to direct transmission between the human population (i.e., infection of an uninfected person without human-to-human interaction). As these findings do not contradict and only partially support previous observational studies, the ultimate source of [the observed outbreaks of SARS-CoV-2 or its associated disease, COVID-19,] remains unknown. ClinicalTrials.gov Identifier: NCT 03700991.

Anonymous Patient Answer

Have there been any new discoveries for treating covid-19?

There have recently been two large-scale clinical trials in China and Europe. One trial, led by Dr. Li Wenliang, was designed to collect a large amount of research data to compare the outcome and recovery rates of patients who received the traditional Chinese medicine with that of those who received [traditional Chinese medicine to treat patients with covid-19.] However, the study was halted due to concerns of the Chinese government over ethical decisions concerning the disclosure of experimental information, such as in disclosing information about the patients' medical treatment before the patients received it.

Anonymous Patient Answer

What are the common side effects of omega-3 (epa+dha)?

This supplement reduces the side effects of epa and dha. The common side effects from the supplement are: headache, flushing of skin, vomiting, dizziness, and abdominal pain. The most common side effects are headaches (n=16%) and flushing of skin (n=7%).

Anonymous Patient Answer

How serious can covid-19 be?

We found that most patients with confirmed [covid-19] infection were not admitted to hospital, but only 20% had symptoms that required urgent medical attention. There is a risk of an excess number of cases if precautions are not taken.

Anonymous Patient Answer

Who should consider clinical trials for covid-19?

Clinical trials are an effective way of testing new treatments and vaccines. If you choose a clinical trial, it helps to understand how well your test dosing, medication, and test regimen is working in your group. It is also helpful for evaluating side effects and figuring out the safest dosage that can be used in future. In the outbreak, clinical trials are necessary and crucial to figuring out how to save survivors and those diagnosed with the disease, but it's also worth noting that clinical trial data in the outbreak are limited and are often misleading. It is important to work with local healthcare leaders and scientists to make sure that clinical trials are handled correctly.

Anonymous Patient Answer
See if you qualify for this trial
Get access to this novel treatment for COVID-19 by sharing your contact details with the study coordinator.